Skip to main content Skip to footer

Harmonizing digital, data and traditional ways of working

Digital transformation in biopharma requires a delicate balance between traditional methods, rapidly emerging technology, and human decision-making. A shift in perspective to focus on change management is imperative. Working in a human+machine mode enables the augmentation of human roles; it requires becoming comfortable and knowledgeable with your data and technology to derive deeper insights, enhance human potential, and increase role effectiveness.

Contributors:

Tom Lehmann

Managing Director – Life Sciences

Chris Braithwaite

Global Head of Drug Development Digital and IT, Novartis

Design for the future and deliver progress over perfection

For Biopharma organizations, the quest to modernize digital, data, and analytics capabilities across Development must focus on near-term wins while planning for the future. There is a sense of urgency for patients seeking better, faster treatments. And this is a non-linear endeavor – iteration and evolution are a given. A compressed transformation approach combined with agile experimentation can deliver tangible benefits quickly and establish a foundation for future growth.

Contributors:

Tom Lehmann

Managing Director – Life Sciences

Michel Rider

VP – Digital, Analytics, and Performance, GSK

Rethink it: Digital is not a thing, digital is a means

When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digital is a means and not the end. The biopharma industry is viewed as knowledge-generating enterprises, and while ever-growing amounts of data present complex challenges, a strong digital core will fuel competitive advantages.

Contributors:

Tom Lehmann

Managing Director – Life Sciences

Jason Bronfeld

Head – Product Development IT, Bristol-Myers Squibb

Driving digital in biopharma podcasts

Life Sciences

Enabling tomorrow’s science through digital

Tom Lehmann talks with Anders Persson, AstraZeneca, about the role of digital and data in the transformation of global drug development.

LISTEN TO THE EPISODE
Life Sciences

Decentralized methods and the future of clinical research

Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community.

LISTEN TO THE EPISODE
Life Sciences

Digital is greater than technology

Tom Lehmann discusses digital strategy and transformation wins with Guido Radack, Vice President, Strategic Initiatives Leader at Bayer.

LISTEN TO THE EPISODE
Life Sciences

From documents to data - Regulatory's future?

Tom and guest Eddie Reilly, Sanofi discuss delivering new therapies to patients more efficiently and how that’s enabled by regulatory affairs.

LISTEN TO THE EPISODE
Life Sciences

In search of the digital thread

Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative.

LISTEN TO THE EPISODE
Life Sciences

Raising the innovation bar in early research and development

Lars and Tom discuss the journey to accelerate research and early development through lab automation...

LISTEN TO THE EPISODE
Life Sciences

Enabling scientific curiosity through digital in drug recovery

Tom and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery.

LISTEN TO THE EPISODE
Life Sciences

Data is the new currency for drug development

Venkat and Tom discuss the critical role of data, design and digital and creating value with patients.

LISTEN TO THE EPISODE
Life Sciences

Digital at the pace of science

Kailash and Tom discuss strategy, how digital is improving patient health, the pace of technology, and future vision.

LISTEN TO THE EPISODE
Life Sciences

A human health care philosophy and digital transformation

Stephen and Tom talk about how Eisai’s focus on human health care is shaping the company’s digital approach.

LISTEN TO THE EPISODE
Life Sciences

Decentralized clinical research

Craig and Tom discuss priorities for clinical trial access and decentralized research methods.

LISTEN TO THE EPISODE
Life Sciences

In search of the digital thread

John and Tom talk about learnings from a digital transformation pilot and improving process.

LISTEN TO THE EPISODE
Life Sciences

The 4 P’s of digital transformation

Debraj and Tom discuss the enabling role of 4 P’s in a successful digital transformation.

LISTEN TO THE EPISODE
Life Sciences

Digital’s positive role in patient health

Tina, Jennifer and Tom discuss the COVID-19 patient-care reset.

LISTEN TO THE EPISODE
Life Sciences

Digital is greater than technology

Guido and Tom discuss clinical innovation, technology investment, decentralized trials and COVID’s role.

LISTEN TO THE EPISODE
Life Sciences

Digital at the pace of science

Kailash and Tom discuss strategy, how digital is improving patient health, the pace of technology, and future vision.

LISTEN TO THE EPISODE
Life Sciences

Digitalization in Biopharma R&D

Join Tom and Katie Miinch for the discussion that ignited our series!

LISTEN TO THE EPISODE

Meet the host

Tom Lehmann
Managing Director – Life Sciences

"It’s fascinating to connect with people in the middle of shaping and delivering transformation, learning about the challenges and opportunities they are experiencing."

I’ve spent the past 25 years working with biopharmaceutical companies across the R&D value chain to understand and address their critical business challenges. During this time, I’ve seen technology (and now digital) evolve from being viewed as an enabler and cost center into something that is now a core part of the dialog to solve the most complex challenges faced by the industry. That evolution was a large part of the decision to start a podcast series that explores the state of digital transformation in the biopharmaceutical industry.